From Public Funds To VCs: Swiss Financing For Swiss Biotech
Innovation Grants And Mid-Stage Raises
While most of the cash for Swiss biotech firms comes from outside the country, around 20% is provided by Swiss entities. Scrip spoke with two of these home-grown supporters of life sciences innovation about the move from academia to industry and their respective investment strategies.
